Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Infective Endocarditis
2005 Standout
High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries
2018 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion
1998
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
2003
Efflux-Mediated Drug Resistance in Bacteria
2004
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Impact of Fluoroquinolone Prophylaxis on Reduced Infection‐Related Mortality among Patients with Neutropenia and Hematologic Malignancies
2005
Kinetic Analysis of the Mechanism and Specificity of Protein-disulfide Isomerase Using Fluorescence-quenched Peptides
1998 StandoutNobel
Antibiotics and Topical Nasal Steroid for Treatment of Acute Maxillary Sinusitis
2007
Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria
2004 Standout
Fluoroquinolone prescribing in the United States: 1995 to 2002
2005
Marine natural products
1990 Standout
Why do bacteria use so many enzymes to scavenge hydrogen peroxide?
2012
Fluoroquinolone resistance among Gram-positive cocci
2002
Streptococcus pneumoniaeBacteremia: Duration of Previous Antibiotic Use and Association with Penicillin Resistance
2003
Mechanisms of multidrug transporters
1997
Optical control of antibacterial activity
2013 StandoutNobel
Antibiotic resistance of bacteria in biofilms
2001 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Community-acquired pneumonia
2003
The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
2008
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
The Science of Antibiotic Discovery
2020 Standout
Clinical Presentation and Bacteriologic Analysis of Infected Human Bites in Patients Presenting to Emergency Departments
2003
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Intranasal Corticosteroids in Management of Acute Sinusitis: A Systematic Review and Meta-Analysis
2012
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
2005
Emergence of Levofloxacin-Resistant Pneumococci in Immunocompromised Adults after Therapy for Community-Acquired Pneumonia
2003
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
2005 Standout
Streptococcus pneumoniae Bacteremia in Patients With Cancer
2005
DENTAL CARIES
2000
The primary transcriptome of the major human pathogen Helicobacter pylori
2010 StandoutNature
Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia
2004
Canadian clinical practice guidelines for acute and chronic rhinosinusitis
2011
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
2003
Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia
2004
Fluoroquinolones: Action and Resistance
2003
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Antibiotic resistance in the environment
2021 Standout
Decreasing β-Lactam Resistance in Pneumococci From the Memphis Region*
2003
Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data
2008
The mar regulon: multiple resistance to antibiotics and other toxic chemicals
1999
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Dental caries
2007 Standout
Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials
2008
Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities
2004
Impact of Initial Antibiotic Choice on Clinical Outcomes in Community-Acquired Pneumonia
2003
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Bacteremia Due to Viridans Group Streptococci with Diminished Susceptibility to Levofloxacin among Neutropenic Patients Receiving Levofloxacin Prophylaxis
2002
Reactions of chlorine with inorganic and organic compounds during water treatment—Kinetics and mechanisms: A critical review
2007 Standout
Guidelines for the management of adult lower respiratory tract infections
2005
Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome
2010
How antibiotics kill bacteria: from targets to networks
2010 Standout
Versatility of Aminoglycosides and Prospects for Their Future
2003
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii
2004
Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysis
2007
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Interactions of Fluoroquinolone Antibacterial Agents with Aqueous Chlorine: Reaction Kinetics, Mechanisms, and Transformation Pathways
2005
Saline nasal irrigation: Its role as an adjunct treatment.
2003
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Treatment of drug-resistant pneumococcal pneumonia
2002
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Oxidative Processes in the Australian Marine Sponge Plakinastrella clathrata: Isolation of Plakortolides with Oxidatively Modified Side Chains
2011
Antisense RNA Modulation of Alkyl Hydroperoxide Reductase Levels in Helicobacter pylori Correlates with Organic Peroxide Toxicity but Not Infectivity
2007
Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies
2012 Standout
Outpatient Care Compared with Hospitalization for Community-Acquired Pneumonia
2005
Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community‐Acquired Pneumonia
2008
The diagnosis and management of sinusitis: A practice parameter update
2005
Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin
1992
Clinical Characteristics at Initial Presentation and Impact of Dual Therapy on the Outcome of Bacteremic Streptococcus pneumoniae Pneumonia in Adults
2004
Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model
1996
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
2000
Antimicrobial Activity of Oleanolic Acid from Salvia officinalis and Related Compounds on Vancomycin-Resistant Enterococci (VRE)
2007
Sampling the Antibiotic Resistome
2006 StandoutScience
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Daptomycin Is Highly Efficacious against Penicillin-Resistant and Penicillin- and Quinolone-Resistant Pneumococci in Experimental Meningitis
2004
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Antibiotics for clinically diagnosed acute rhinosinusitis in adults
2012
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
2001 Standout
Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pragmatic randomized double-blind controlled trial in family practice.
2002
Review
1997
Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
2006
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
2005
Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniae
2003
Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics
1997
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Clinical practice guideline: Adult sinusitis
2007 Standout
Relative Fitness of Fluoroquinolone-resistantStreptococcus pneumoniae
2005
The Bacterial Species Challenge: Making Sense of Genetic and Ecological Diversity
2009 Science
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Ross Davidson being referenced
A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae
2001
Antimicrobial Activity of Subinhibitory Concentrations of Aminoglycosides against <i>Pseudomonas aeruginosa</i> as Determined by the Killing-Curve Method and the Postantibiotic Effect
1991
A Cross‐Canada Surveillance of Antimicrobial Resistance in Respiratory Tract Pathogens
1998
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
2002
Bacteremic pneumococcal pneumonia associated with macrolide failure
2006
An Ortholog of OxyR in Legionella pneumophila Is Expressed Postexponentially and Negatively Regulates the Alkyl Hydroperoxide Reductase ( ahpC2D ) Operon
2008
Enterobacter cloacae Complex Isolates Harboring bla NMC-A or bla IMI -Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids
2017
Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae : Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance
2000
Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa
1994
Compensatory Functions of Two Alkyl Hydroperoxide Reductases in the Oxidative Defense System ofLegionella pneumophila
2006
Acute Bacterial Sinusitis in Adults: Management in the Primary Care Setting
2002
Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli
1992
Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones
1995
Antimicrobial treatment options in the management of odontogenic infections.
1998
Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro
1994
In Vitro Antimicrobial Susceptibilities of Streptococcus pneumoniae Clinical Isolates Obtained in Canada in 2002
2004
Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniae
2001
In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth
1993
A practical guide for the diagnosis and treatment of acute sinusitis.
1997
Human serum enhances the postantibiotic effect of fluoroquinolones against Staphylococcus aureus
1991
Accuracy of Phenotypic and Genotypic Testing for Identification of Streptococcus pneumoniae and Description of Streptococcus pseudopneumoniae sp. nov
2004